Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETV3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | PRDM7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | KRTAP4-4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PDZD11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | GRB10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | RPS6KB1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | DNAJC25 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | P2RY1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | TRAK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |